M&T Bank’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,061
| Closed | -$536K | – | 1585 |
|
|
2025
Q1 | $536K | Sell |
4,061
-2,240
| -36% | -$295K | ﹤0.01% | 1039 |
|
|
2024
Q4 | $526K | Buy |
6,301
+138
| +2% | +$11.5K | ﹤0.01% | 1147 |
|
|
2024
Q3 | $451K | Buy |
6,163
+1,642
| +36% | +$120K | ﹤0.01% | 1193 |
|
|
2024
Q2 | $310K | Buy |
4,521
+123
| +3% | +$8.43K | ﹤0.01% | 1300 |
|
|
2024
Q1 | $304K | Sell |
4,398
-382
| -8% | -$26.4K | ﹤0.01% | 1318 |
|
|
2023
Q4 | $342K | Buy |
4,780
+774
| +19% | +$55.4K | ﹤0.01% | 1261 |
|
|
2023
Q3 | $209K | Sell |
4,006
-1,168
| -23% | -$60.8K | ﹤0.01% | 1432 |
|
|
2023
Q2 | $327K | Sell |
5,174
-469
| -8% | -$29.7K | ﹤0.01% | 1275 |
|
|
2023
Q1 | $305K | Sell |
5,643
-575
| -9% | -$31.1K | ﹤0.01% | 1293 |
|
|
2022
Q4 | $329K | Buy |
6,218
+330
| +6% | +$17.5K | ﹤0.01% | 1254 |
|
|
2022
Q3 | $274K | Buy |
5,888
+2,196
| +59% | +$102K | ﹤0.01% | 1307 |
|
|
2022
Q2 | $211K | Sell |
3,692
-1,560
| -30% | -$89.2K | ﹤0.01% | 1357 |
|
|
2022
Q1 | $322K | Sell |
5,252
-1,552
| -23% | -$95.2K | ﹤0.01% | 1167 |
|
|
2021
Q4 | $356K | Buy |
6,804
+82
| +1% | +$4.29K | ﹤0.01% | 1174 |
|
|
2021
Q3 | $251K | Sell |
6,722
-549
| -8% | -$20.5K | ﹤0.01% | 1328 |
|
|
2021
Q2 | $297K | Buy |
7,271
+256
| +4% | +$10.5K | ﹤0.01% | 1266 |
|
|
2021
Q1 | $239K | Sell |
7,015
-3,938
| -36% | -$134K | ﹤0.01% | 1337 |
|
|
2020
Q4 | $348K | Sell |
10,953
-9,223
| -46% | -$293K | ﹤0.01% | 1257 |
|
|
2020
Q3 | $518K | Buy |
20,176
+3,071
| +18% | +$78.8K | ﹤0.01% | 969 |
|
|
2020
Q2 | $439K | Buy |
17,105
+5,369
| +46% | +$138K | ﹤0.01% | 995 |
|
|
2020
Q1 | $180K | Buy |
+11,736
| New | +$180K | ﹤0.01% | 1342 |
|
|
2015
Q4 | – | Sell |
-8,250
| Closed | -$330K | – | 1762 |
|
|
2015
Q3 | $330K | Buy |
+8,250
| New | +$330K | ﹤0.01% | 1277 |
|